Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
Cancer Immunotherapy Month is a series of educational and social events designed to raise awareness of this promising new cancer treatment. Check out some of the exciting activities we have planned for you!
Dr. Jill O'Donnell-Tormey, CRI CEO and Director of Scientific Affairs, reflects on a decade of progress and about what's new in June for the 10th Annual Cancer Immunotherapy Month.
Run, Walk, or Move with us during the month of June to support the next great breakthroughs in cancer immunotherapy research.
Immunotherapy is reshaping survivorship for many cancer patients. We explore how patients and doctors are navigating these new experiences.
Meet Sharon, who was one of the first patients to be treated successfully with ipilimumab for melanoma.
National Cancer Survivors Day® is a celebration for those who have survived, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community.
Learn about headline-grabbing research, practice-changing medicine, and new innovations in cancer immunotherapy from the world's largest oncology conference.
Raise awareness of the lifesaving potential of cancer immunotherapy on social media with the hashtag #Immune2Cancer.
Meet Sonia, who received CAR T cell therapy for an aggressive type of non-Hodgkin lymphoma.
Follow a day in the life of CRI Lloyd J. Old STAR Amanda Lund, Ph.D., of New York University.
With a family history of cancer, Barry understood the dangers of both the disease and standard treatments when he enrolled in an immunotherapy clinical trial.
In this webinar for patients and caregivers, oncologist Laurie Glimcher and patient advocate Sunshine Pegues address both the science and experience of cancer immunotherapy.
Follow a day in the life of the first child treated with CAR T cell therapy—ten years cancer-free.
Diversity in scientific thinking and equitable care is necessary to advance cancer research, treatments, and cures for all people.
Matilde first heard about cancer immunotherapy as the revolutionary treatment that Jimmy Carter was receiving before she enrolled in a clinical trial testing immunotherapy for lung cancer.
*Los resultados de la inmunoterapia pueden variar de un paciente a otro.
Comuníquese con nosotros
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
Rare and ultra-rare cancers affect around 20,000 people in the United States alone, according to Foundation Medicine, Inc. Immunotherapy research in some of the more common cancers and the identification of biomarkers that can predict patient responses is opening this new approach to cancer treatment up to patients whose cancers currently receive little direct attention.
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.